PAMELA VELARDI: Open Payments
NPI 1073710927 · LA MESA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$891 in 9 payments from 6 companies in 2025. Trend: 2023 $147 · 2024 $450 · 2025 $891
Food & beverage: $891
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 2 | $282 |
| Alkermes, Inc. | 3 | $248 |
| Otsuka America Pharmaceutical, Inc. | 1 | $121 |
| E.R. Squibb & Sons, L.L.C. | 1 | $121 |
| Janssen Scientific Affairs, LLC | 1 | $99 |
| Lundbeck LLC | 1 | $20 |
Products named: INVEGA SUSTENNA, ARISTADA, REXULTI, COBENFY, LYBALVI.
Industry payments across CA — which companies pay providers there.
